Skip to main content
×
×
Home

Role of p.r.n. antimuscarinic medication in the treatment of antipsychotic-induced extrapyramidal movement disorders

  • Luke Birmingham (a1), Norman McClelland (a1) and Caroline Bradley (a1)
Extract

The antimuscarinic drugs procyclidine, orphenadrine, benzhexol and benztropine are used in psychiatric practice to alleviate the extrapyramidal effects of antipsychotic medication. These drugs may be prescribed on a regular, as-required or single-dose basis. They are usually taken by mouth, in tablet or liquid form, but for rapid onset of action procyclidine and benztropine can be given by intramuscular or intravenous injection.

    • Send article to Kindle

      To send this article to your Kindle, first ensure no-reply@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about sending to your Kindle. Find out more about sending to your Kindle.

      Note you can select to send to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be sent to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

      Find out more about the Kindle Personal Document Service.

      Role of p.r.n. antimuscarinic medication in the treatment of antipsychotic-induced extrapyramidal movement disorders
      Available formats
      ×
      Send article to Dropbox

      To send this article to your Dropbox account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your <service> account. Find out more about sending content to Dropbox.

      Role of p.r.n. antimuscarinic medication in the treatment of antipsychotic-induced extrapyramidal movement disorders
      Available formats
      ×
      Send article to Google Drive

      To send this article to your Google Drive account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your <service> account. Find out more about sending content to Google Drive.

      Role of p.r.n. antimuscarinic medication in the treatment of antipsychotic-induced extrapyramidal movement disorders
      Available formats
      ×
Copyright
This is an Open Access article, distributed under the terms of the Creative Commons Attribution (CC-BY) license (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted re-use, distribution, and reproduction in any medium, provided the original work is properly cited.
Corresponding author
Correspondence
References
Hide All
Bamrah, J. S., Kumar, V., Krska, J., et al (1986) Interactions between procyclidine and neuroleptic drugs. Some pharmacological and clinical aspects. British Journal of Psychiatry, 149, 726 733.
Barnes, T. R. E. & Phillips, M. A. (1996) Antipsychotic-induced extrapyramidal symptoms. Role of anticholinergic drugs in treatment. CNS Drugs, 6, 315 330.
Birmingham, L., McClelland, N. & Bradley, C. (1999) p.r.n. prescribing and administration of antimuscarinic medication. Psychiatric Bulletin, 23, 184 185.
Blaisdell, G. D. (1994) Akathisia. A comprehensive review and treatment summary. Pharmacopsychiatry, 27, 139 146.
Calev, A. (1984) Anticholinergic drugs and memory. British Journal of Psychiatry, 143, 422 423.
Ebel, H. (1994) Therapy of neuroleptic-induced extrapyramidal movement disorders. Neurology, Psychiatry & Brain Research, 2, 140 151.
Holloman, L. C. & Marder, S. R. (1997) Management of acute extrapyramidal effects induced by antipsychotic drugs. American Journal of Health-System Pharmacy, 54, 2461 2477.
Johnson, A. L., Hollister, L. E. & Berger, P. A. (1981) The anticholinergic intoxication syndrome: diagnosis and treatment. Journal of Clinical Psychiatry, 42, 313 317.
Marken, P. A., Stoner, S. C. & Bunker, M. T. (1996) Anticholinergic drug abuse and misuse. CNS Drugs, 5, 190 199.
Pullen, G. P., Best, N. R. & Maguire, J. (1984) Anticholinergic drug abuse: a common problem? British Medical Journal, 289, 612 613.
World Health Organization Heads of Centres Collaborating in WHO Co-ordinated Studies on Biological Aspects of Mental Illness (1990) Prophylactic use of anticholinergics in patients on long-term neuroleptic treatment. A consensus statement. British Journal of Psychiatry, 156, 412.
Recommend this journal

Email your librarian or administrator to recommend adding this journal to your organisation's collection.

BJPsych Bulletin
  • ISSN: 0955-6036
  • EISSN: 1472-1473
  • URL: /core/journals/bjpsych-bulletin
Please enter your name
Please enter a valid email address
Who would you like to send this to? *
×

Metrics

Full text views

Total number of HTML views: 0
Total number of PDF views: 4 *
Loading metrics...

Abstract views

Total abstract views: 23 *
Loading metrics...

* Views captured on Cambridge Core between 2nd January 2018 - 23rd July 2018. This data will be updated every 24 hours.

Role of p.r.n. antimuscarinic medication in the treatment of antipsychotic-induced extrapyramidal movement disorders

  • Luke Birmingham (a1), Norman McClelland (a1) and Caroline Bradley (a1)
Submit a response

eLetters

No eLetters have been published for this article.

×

Reply to: Submit a response


Your details


Conflicting interests

Do you have any conflicting interests? *